Harry J. Gould, III, MD, PhD On June 26, 2021, Johnson & Johnson confirmed that in 2020, as part of a $230M settlement with the State of New York, they discontinued promotion and distribution of opioid products in the State of New York. The settlement was made in response to efforts to mitigate the unprecedented […]
Olivia Lee and Lawrence Robbins, MD Introduction Over 325 million doses of COVID-19 vaccines have been distributed in the United States, and much of the country is looking forward to a return to normalcy. For many, the widespread access to vaccines signaled the pandemic’s defeat, but for millions of COVID-19 survivors, the sequelae following acute […]
ANA2021’s Virtual Annual Meeting is set for October 17-19 with an Opening Symposium on October 16 and registration is now open! All full registrations include access to the ANA2021 Meeting Recordings package, ensuring you won’t miss out on the latest neurological research even if your schedule should change. Registration also includes complimentary access to the SIG Series […]
Harry J. Gould, III, MD, PhD Pain occurs in both acute and chronic forms. In its acute form, pain is a modality that is essential for survival and is the signal that most frequently brings people to the attention of the healthcare professional. Many cases of simple acute pain are readily treated without difficulty by […]
The CGRP Monoclonal Antibodies for Migraine Are a Prime Example Lawrence Robbins, M.D. This letter is in response to an excellent July, 2020 article “Migraine and CGRP Monoclonal Antibodies: A Review of Cardiovascular Side Effects and Safety Profile” (Boldig and Butala) in the International Journal of Neurology and Neurotherapy. (1) There are a plethora of […]
A year ago, the United States was in the midst of understanding and dealing with the complexities of the “Opioid Epidemic”, what until then had been considered the greatest healthcare crisis in U.S. history. Although improvements in some aspects of the crisis were starting to be realized as a result of the development of best evidence-based practice guidelines and the implementation […]
Lawrence Robbins, MD Individuals suffering from chronic pain often have psychiatric comorbidities. For instance, among those with chronic migraine approximately 9% fit into the bipolar spectrum. (1) This article discusses a representative case of a patient with chronic migraine and bipolar disorder as well as epilepsy and irritable bowel syndrome. Caitlin is a 28-year-old female […]
Bert Ray, MD Laser therapy has been utilized for multiple medical problems, as the light energy improves mitochondrial function in cells that are involved with medical illnesses, has an anti-inflammatory effect, boosts the immune response, and restores oxidative redox balance. Thus, the laser energy helps rebalance the oxidative redox system that underlies the inflammation involved […]
It is with deep sadness that we recognize the life and contributions of John Satterthwaite, MD who transitioned from this earthly world last month. John’s perspective on the history and devotion to the mission of SPS were priceless. Many have no doubt that the SPS would not exist today it were not for the careful nurturing and stewardship of John during the last 34 years […]
Benjamin Johnson, MD I would like to thank our president, Ann Quinlan-Colwell, PhD, APN, for the invitation to write an article regarding diversity in our field of pain medicine. As the first president of the Southern Pain Society possessing African-American heritage, I was overwhelmed with the […]